Literature DB >> 12353856

Local release of human neutrophil lipocalin (HNL), IL-8, and TNF-alpha is decreased as response to topical prednisolone treatment in distal ulcerative colitis and proctitis.

Per Sangfelt1, Marie Carlson, Magnus Thörn, Shengyuan Xu, Lars Lööf, Yngve Raab.   

Abstract

The local release of human neutrophil lipocalin, considered to be highly specific for neutrophil granulocyte activation, and interleukin-8 and tumor necrosis factor-alpha were studied in 11 patients with distal ulcerative colitis and proctitis before and during treatment with steroid enemas. A rectal perfusion technique for sampling and specific immunoassays for analysis were used. In responders (N = 8) the concentrations of all proteins decreased during the study. There was a close correlation between human neutrophil lipocalin concentrations and treatment response. Tumor necrosis factor-alpha showed an initial decline in concentrations irrespective of treatment outcome and preceded the decline of human neutrophil lipocalin and interleukin-8. We conclude that decreased neutrophil degranulation is correlated with treatment outcome. Furthermore, an important role of tumor necrosis factor-alpha in the process of stimulating neutrophil activation and degranulation in ulcerative colitis is suggested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12353856     DOI: 10.1023/a:1019681030784

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils.

Authors:  L Kjeldsen; C Koch; K Arnljots; N Borregaard
Journal:  J Immunol Methods       Date:  1996-11-13       Impact factor: 2.303

Review 2.  Release of inflammatory mediators from stimulated neutrophils.

Authors:  G Weissmann; J E Smolen; H M Korchak
Journal:  N Engl J Med       Date:  1980-07-03       Impact factor: 91.245

Review 3.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.

Authors:  A Keshavarzian; R D Fusunyan; M Jacyno; D Winship; R P MacDermott; I R Sanderson
Journal:  Am J Gastroenterol       Date:  1999-03       Impact factor: 10.864

5.  Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans.

Authors:  J B Cowland; N Borregaard
Journal:  Genomics       Date:  1997-10-01       Impact factor: 5.736

6.  The development of an assay for human neutrophil lipocalin (HNL)--to be used as a specific marker of neutrophil activity in vivo and vitro.

Authors:  S Y Xu; C G Petersson; M Carlson; P Venge
Journal:  J Immunol Methods       Date:  1994-05-16       Impact factor: 2.303

7.  Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis.

Authors:  Y Raab; B Gerdin; S Ahlstedt; R Hällgren
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

8.  Intraluminal colonic release of immunoreactive tumour necrosis factor in chronic ulcerative colitis.

Authors:  F Casellas; M Papo; F Guarner; M Antolín; J R Armengol; J R Malagelada
Journal:  Clin Sci (Lond)       Date:  1994-10       Impact factor: 6.124

9.  Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts.

Authors:  R M Strieter; S H Phan; H J Showell; D G Remick; J P Lynch; M Genord; C Raiford; M Eskandari; R M Marks; S L Kunkel
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

10.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  2 in total

1.  Accumulation, activation, and survival of neutrophils in ulcerative colitis: regulation by locally produced factors in the colon and impact of steroid treatment.

Authors:  Maria Lampinen; Per Sangfelt; Yesuf Taha; Marie Carlson
Journal:  Int J Colorectal Dis       Date:  2008-07-02       Impact factor: 2.571

2.  The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.

Authors:  Arne Egesten; Mette Eliasson; Anders I Olin; Jonas S Erjefält; Anders Bjartell; Per Sangfelt; Marie Carlson
Journal:  Int J Colorectal Dis       Date:  2007-08-17       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.